Global Gaucher Disease Market to Grow at a CAGR of 7.60% From 2015 to 2019: Radiant Insights, Inc.
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 07/09/15 -- Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out of which there are four most prominent mutations that lead to more than half of the Gaucher disease globally.
Some people may have no symptoms of this disease, while some experience severe complications. Some of the clinical manifestations of this disease are hepatosplenomegaly, anemia, thrombocytopenia, and skeletal abnormalities.
This report covers the present scenario and the growth prospects of the Global for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of various drugs used in the therapy of Gaucher disease, which includes:
Enzyme replacement therapy
Substrate reduction therapy
Based on the type of molecule used for the treatment of Gaucher disease, the market is categorized into two segments:
Biologics
Small Molecules
Based on the route of administration adopted for the treatment of Gaucher disease, the market is categorized into two segments:
Oral
Parenteral
Based on the dosage forms of the drugs used to treat the disease, the Global Gaucher Disease market is categorized into two segments:
Solid
Liquid
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction 06. Disease Overview
06.1 Understanding the Disease
06.1.1 Types of Gaucher Disease
06.1.2 Symptoms
06.1.3 Diagnosis
06.2 Etiology
06.3 Epidemiology
06.4 Clinical Manifestations
06.5 Management
06.5.1 Enzyme Replacement Therapy
06.5.2 Substrate Reduction Therapy
06.6 Economic Burden
07. Pipeline Analysis
08. Market Landscape
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.07.2015 - 07:00 Uhr
Sprache: Deutsch
News-ID 1371189
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Health & Nutrition
Anmerkungen:
Diese Pressemitteilung wurde bisher 114 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Gaucher Disease Market to Grow at a CAGR of 7.60% From 2015 to 2019: Radiant Insights, Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Radiant Insights, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
